Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 2Neoplasms 2Urinary Tract Infections 1Tuberculosis, Pulmonary 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Patient Satisfaction 1Neutropenia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Lung Neoplasms 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypoxia 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1

Interventions

alfatide II 1Thoracotomy 1Propofol 1Fluorodeoxyglucose F18 1Drug Delivery Systems 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tuberculosis, Pulmonary × Alfentanil × Clear all
NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡